Using the nerve cells of sea snails, researchers reverse memory loss by determining when cells were primed for learning. Retraining cells with the use of an optimized training schedule helped compensate for memory loss.
Researchers discover a role for long noncoding RNA in brain development and neurodegenerative diseases.
As Alzheimer's disease progresses, microglial cells lose two important biological functions affecting their ability to remove cell fragments and motility towards acute lesions.
Researchers evaluate the pathological impact of single incident TBI and mild, repetitive traumatic brain injury, in order to learn which measures need to be taken to identify risk, early incidence and to reduce long term complications associated with TBI.
Adapting two dimensional culture methods to grow 3-D neuron structures from induced pluripotent stem cells, researchers may be able to model and study neurodegenerative disorders such as Alzheimer's disease.
A new study finds increased amyloid levels in the brains of unmedicated hypertensive adults with a genetic risk factor for Alzheimer's disease.
Researchers develop new medical records software which helps monitor the health of the aging brain.
Buphenyl (sodium phenylbutyrate), a medication approved for the treatment of hyperammonemia, could help prevent the progression of Alzheimer's disease, a new study finds.
Researchers used a specific molecule in green tea extract, EGCG, to control metal associated amyloid beta aggregates associated with Alzheimer's disease and other neurodegenerative disorders.
Researchers identify a novel signaling pathway that activates the parkin gene and prevents stress induced neuronal cell death.
Using transgenic mice with specially designed gene fragments derived from bacteria and human cells, researchers were able to control the production of amyloid beta peptide using antibiotics.
A new study identifies a potential treatment window of several years for plaques in the brain considered to cause memory loss in diseases such as Alzheimer's.